Treatment of Active Tetanus
Patients with developing tetanus require immediate intensive care management with human tetanus immunoglobulin (HTIG), antibiotics, aggressive supportive care including mechanical ventilation, and deep sedation with neuromuscular blockade for severe cases.
Immediate Interventions
Neutralize Circulating Toxin
- Administer human tetanus immunoglobulin (HTIG) immediately upon diagnosis to neutralize unbound tetanus toxin 1
- Standard dose: 3,000-6,000 IU intramuscularly (some protocols use up to 10,000 IU)
- Intrathecal immunoglobulin administration has emerging evidence but remains investigational 2
- Note: Immunoglobulin does NOT reverse toxin already bound to nerve endings—it only neutralizes circulating toxin
Eliminate the Source
- Wound debridement: Thoroughly clean and debride any wounds, even minor ones, to remove Clostridium tetani spores and vegetative bacteria 1
- Antibiotic therapy: Metronidazole 500 mg IV every 6-8 hours for 7-10 days is preferred over penicillin (which may theoretically worsen spasms due to GABA antagonism) 1, 2
- Alternative: Penicillin G 2-4 million units IV every 4-6 hours if metronidazole unavailable
Active Immunization
- Administer tetanus toxoid vaccine (0.5 mL IM) at a different site from immunoglobulin 1
- Critical caveat: Natural tetanus infection does NOT confer immunity—survivors must complete the full primary vaccination series 1
Airway and Respiratory Management
Early Intubation Strategy
- Tracheostomy is preferred over prolonged endotracheal intubation for severe tetanus (Ablett grade III-IV) 3, 1
- Most severe cases require tracheostomy given the prolonged ICU course (median 27.5 days) 3
- Mechanical ventilation is necessary for respiratory muscle spasms and to facilitate deep sedation 3, 4
Control of Muscle Spasms
Sedation Protocol
- Benzodiazepines are first-line for spasm control 1, 2
- Diazepam: Start 10-40 mg IV every 2-4 hours; may require extremely high doses (up to 600 mg/day)
- Midazolam infusion: 0.1-0.4 mg/kg/hour for continuous sedation
Neuromuscular Blockade
- Required in more than half of severe cases when benzodiazepines alone are insufficient 3, 1
- Vecuronium or rocuronium preferred (non-depolarizing agents)
- Use only with adequate sedation and mechanical ventilation
Alternative Agents
- Propofol infusion for refractory spasms 1, 2
- Magnesium sulfate (loading dose 5g IV, then 2-3 g/hour infusion) may help control spasms and autonomic instability 1, 2
- Baclofen (intrathecal or oral) has been used but evidence is limited 2
Management of Autonomic Dysfunction
Cardiovascular Instability
- Autonomic dysfunction is the leading cause of death in modern intensive care 4
- Manifests as: labile hypertension/hypotension, tachycardia/bradycardia, arrhythmias, sudden cardiac arrest
- Magnesium sulfate infusion may attenuate autonomic instability 1, 2
- Avoid beta-blockers (associated with sudden death) 4
- Use short-acting agents for hypertension (esmolol with extreme caution, or morphine)
- Maintain adequate sedation to minimize catecholamine surges
Supportive Care and Complication Prevention
Infection Control
- Pulmonary infections occur in >80% of severe cases 3
- More than half develop antimicrobial-resistant organisms 3
- Strict ventilator-associated pneumonia prevention protocols
- Early mobilization when spasms controlled
Nutritional Support
- High caloric requirements due to continuous muscle activity
- Enteral nutrition preferred when safe (dysphagia is common early) 3
DVT Prophylaxis
- Pharmacologic prophylaxis with low molecular weight heparin
- Sequential compression devices
Minimize Stimulation
- Quiet, darkened room
- Minimize unnecessary procedures and stimulation that trigger spasms
- Cluster nursing care
Clinical Monitoring
Disease Severity Assessment
Early recognition is challenging—dysphagia and generalized muscle hypertonia are more common initial presentations than classic trismus and opisthotonos 3. This is a critical pitfall leading to delayed diagnosis.
Expected Course
- ICU length of stay: median 27.5 days for severe cases 3
- Mortality: 16.7% with modern intensive care 3, but ranges 20-50% depending on resources 4
- Recovery is slow; spasms gradually decrease over weeks
Common Pitfalls to Avoid
- Delaying immunoglobulin administration while awaiting confirmatory tests—tetanus is a clinical diagnosis requiring immediate treatment
- Assuming vaccination history provides protection—even fully vaccinated individuals can develop tetanus without boosters 5
- Using beta-blockers for autonomic instability—associated with sudden death 4
- Inadequate sedation before neuromuscular blockade—always ensure deep sedation first
- Forgetting to vaccinate survivors—natural infection does NOT confer immunity 1
Post-Recovery Vaccination
Complete the 3-dose primary tetanus vaccination series after recovery: initial dose (given during acute illness), second dose at 4 weeks, third dose at 6-12 months 6, 1. This is non-negotiable as tetanus infection provides no immunity.
The prognosis depends heavily on ICU resources, early recognition, and aggressive management of both spasms and autonomic dysfunction 3, 4.